Sphincterotomy during endoscopic biliary drainage in cholangitis with sepsis-induced coagulopathy increases bleeding without clinical benefits

Read full text
Authors: Yasuhisa Hiroshima, Ryota Sagami, Naosuke Kuraoka, Tatsuya Noguchi, Yasusato Matsuda, Takero Terayama, Yoshifumi Azuma, Takao Sato, Hidefumi Nishikori, Hideho Honda, Yasuhiko Goto, Haruna Noguchi
+23 more Satoshi Fukuchi, Kaoru Ômori, Mitsuteru Motomura, Tadayoshi Okimoto, Okamoto Kazuhisa, Hideki Mori, Tatsuya Sato, Kosuke Takahashi, Eisuke Ozawa, Eriko Ikeda, Atsushi Kanno, Shunsuke Komoto, Takehiko Koga, Yusuke Ishida, Kiyoyuki Kobayashi, Makoto Hinokuchi, Ryo Ihara, Takahiro Ueda, Nao Fujimori, Osamu Matsunari, Chishio Noguchi, Kazuhiro Mizukami, Kazunari Murakami
Cited by: 0
References: 36

Abstract

BACKGROUND: Acute cholangitis (AC) is life-threatening, requiring urgent biliary drainage. Endoscopic biliary drainage (EBD), often combined with endoscopic sphincterotomy (EST), may prevent post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP). However, sepsis-induced coagulopathy (SIC) increases bleeding risk, raising concerns about EST safety. AIMS: To evaluate the risk of adverse events (AEs) and clinical outcomes associated with EBD with or without EST in patients with AC and SIC. METHODS: In this retrospective multicentre cohort study, data from enrolled patients were analysed using propensity score matching, and outcomes were compared between EST and non-EST groups. The primary endpoint was the AE rate difference between EBD with and without EST. Secondary endpoints included differences in clinical outcomes. RESULTS: Among 238 patients, 72 underwent EST and 166 did not. The AE incidence, particularly bleeding-related (11.1% vs. 0.6%, P

Fields of Study & Subjects

Gallbladder and Bile Duct Disorders Pediatric Hepatobiliary Diseases and Treatments Pancreatitis Pathology and Treatment

Publication details

Journal / source
Digestive and Liver Disease
Volume
58
Issue
4
Pages
527–533
Publication date
7 February 2026
Language
EN